Cargando…
Foetal Cell Transplantation for Parkinson's Disease: Focus on Graft-Induced Dyskinesia
Transplantation of dopamine- (DA-) rich foetal ventral mesencephalic cells emerged as a promising therapy for Parkinson's disease (PD), as it allowed significant improvement of motor symptoms in several PD patients in open-label studies. However, double-blind clinical trials have been largely d...
Autores principales: | Tronci, Elisabetta, Fidalgo, Camino, Carta, Manolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736211/ https://www.ncbi.nlm.nih.gov/pubmed/26881178 http://dx.doi.org/10.1155/2015/563820 |
Ejemplares similares
-
Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease
por: Shin, Eunju, et al.
Publicado: (2012) -
Serotonin System Implication in l-DOPA-Induced Dyskinesia: From Animal Models to Clinical Investigations
por: Carta, Manolo, et al.
Publicado: (2014) -
Dyskinesia in Parkinson's Disease Therapy
por: Carta, Anna Rosa, et al.
Publicado: (2012) -
Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease
por: Greene, Paul E., et al.
Publicado: (2021) -
“Cueing” for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2016)